Table 2. Unambiguously expressed chemokines and chemokine receptors in IFN-treated preosteclasts.
| Expressed chemokine | Expressed chemokine receptor |
|---|---|
| CCL2 (MCP-1) | CCR1 |
| CCL3*(MIP-1 α) | CCR5 |
| CCL4* (MIP-1 β) | CCRL2 |
| CCL7* (MCP-3) | |
| CCL8* (MCP-2) | |
| CXCL1 (GRO-α) | |
| CXCL2 (GRO-β) | |
| CXCL3 (GRO-γ) | |
| CXCL5 (ENA-78) | |
| CXCL6 (GCP-2) | |
| CXCL7 (NAP-2) | |
| CXCL8 (IL-8) | |
| CXCL9 (MIG) | |
| CXCL10 (IP-10) | |
| CXCL11 (I-TAC) | |
| CXCL16 | |
| CKLF | |
| CKLFSF6 | |
| CKLFSF7 |
Data are from Affymetrix HG-U133 plus 2.0 hybridization. Boldface type, expression confirmed by quantitative PCR analysis.
*
Chemokine known to interact with CCR1 or CCR5